Frazier Life Sciences Public Fund, L.P. is of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 0 shares of ADVM, which is worth approximately $0. The most recent transaction as insider was on Dec 09, 2025, when has been sold 4,288,949 shares (Common Stock) at a price of $3.56 per share, resulting in proceeds of $15,268,658. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Frazier Life Sciences Public Fund, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2025
SELL
Disposition due to a tender of shares in a change of control transaction
$15,268,658 $3.56 p/Share
4,288,949 Reduced 100.0%
0 Common Stock

Also insider at

VRDN
Viridian Therapeutics, Inc.\DE Healthcare
FLS

Frazier Life Sciences Public Fund, L.P.

Seattle, WA

Track Institutional and Insider Activities on ADVM

Follow Adverum Biotechnologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADVM shares.

Notify only if

Insider Trading

Get notified when an Adverum Biotechnologies, Inc. insider buys or sells ADVM shares.

Notify only if

News

Receive news related to Adverum Biotechnologies, Inc.

Track Activities on ADVM